.

.


The information on this site is from academic and research studies. Applicability to humans must be determined by a licensed medical professional.

Partial list of Citations used for Recommendations or Conditions

Recent additions may not be included. There is an intentional delay in making those available.

  1. [Sensitivity to antibiotics of bacteria from nosocomial infections. Evolution in resuscitation services of military hospitals].
    Presse medicale (Paris, France : 1983) (Presse Med ) Vol: 29 Issue 27 Pages: 1497-503
    Pub: 2000 Sep 23 Epub:
    • Garrabé E
    • Cavallo JD
    • Brisou P
    • Chapalain JC
    • Coué JC
    • Courrier P
    • Granic G
    • Hervé V
    • Koeck JL
    • Morillon M
    • Claude JD
    • Rouby Y
    • Teyssou R

  2. Extensive impact of non-antibiotic drugs on human gut bacteria.
    Nature (Nature ) Vol: 555 Issue 7698 Pages: 623-628
    Pub: 2018 Mar 29 Epub: 2018 Mar 19
    • Maier L
    • Pruteanu M
    • Kuhn M
    • Zeller G
    • Telzerow A
    • Anderson EE
    • Brochado AR
    • Fernandez KC
    • Dose H
    • Mori H
    • Patil KR
    • Bork P
    • Typas A

  3. Modulation of the metabiome by rifaximin in patients with cirrhosis and minimal hepatic encephalopathy.
    PloS one (PLoS One ) Vol: 8 Issue 4 Pages: e60042
    Pub: 2013 Epub: 2013 Apr 2
    • Bajaj JS
    • Heuman DM
    • Sanyal AJ
    • Hylemon PB
    • Sterling RK
    • Stravitz RT
    • Fuchs M
    • Ridlon JM
    • Daita K
    • Monteith P
    • Noble NA
    • White MB
    • Fisher A
    • Sikaroodi M
    • Rangwala H
    • Gillevet PM

  4. In vitro potentiation of carbapenems with tannic acid against carbapenemase-producing enterobacteriaceae: exploring natural products as potential carbapenemase inhibitors.
    Journal of applied microbiology (J Appl Microbiol ) Vol: 126 Issue 2 Pages: 452-467
    Pub: 2019 Feb Epub: 2018 Nov 23
    • Somboro AM
    • Osei Sekyere J
    • Amoako DG
    • Kumalo HM
    • Khan R
    • Bester LA
    • Essack SY

  5. Modulation of the gut microbiota composition by rifaximin in non-constipated irritable bowel syndrome patients: a molecular approach
    Clinical and Experimental Gastroenterology (Clin Exp Gastroenterol ) Vol: 8 Issue Pages: 309-325
    Pub: 2015 Dec 4 Epub: 2015 Dec 4
    • Soldi S
    • Vasileiadis S
    • Uggeri F
    • Campanale M
    • Morelli L
    • Fogli MV
    • Calanni F
    • Grimaldi M
    • Gasbarrini A

  6. Argentinean collaborative multicenter study on the in vitro comparative activity of piperacillin-tazobactam against selected bacterial isolates recovered from hospitalized patients.
    Diagnostic microbiology and infectious disease (Diagn Microbiol Infect Dis ) Vol: 47 Issue 3 Pages: 527-37
    Pub: 2003 Nov Epub:
    • Casellas JM
    • Tomé G
    • Bantar C
    • Bertolini P
    • Blázquez N
    • Borda N
    • Couto E
    • Cudmani N
    • Guerrera J
    • Juárez MJ
    • López T
    • Littvik A
    • Méndez E
    • Notario R
    • Ponce G
    • Quinteros M
    • Salamone F
    • Sparo M
    • Sutich E
    • Vaylet S
    • Wolff L

  7. Etiologies of community-onset urinary tract infections requiring hospitalization and antimicrobial susceptibilities of causative microorganisms.
    Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi (J Microbiol Immunol Infect ) Vol: 50 Issue 6 Pages: 879-885
    Pub: 2017 Dec Epub: 2016 Dec 18
    • Chiu CC
    • Lin TC
    • Wu RX
    • Yang YS
    • Hsiao PJ
    • Lee Y
    • Lin JC
    • Chang FY

  8. [Relationship between the sensitivity of Pseudomonas aeruginosa and the post-antibiotic effect of sparfloxacin and ciprofloxacin].
    Revista espanola de quimioterapia : publicacion oficial de la Sociedad Espanola de Quimioterapia (Rev Esp Quimioter ) Vol: 11 Issue 4 Pages: 333-8
    Pub: 1998 Dec Epub:
    • Pastor A
    • Cantón E
    • Pemán J

  9. Metronidazole: in vitro activity, pharmacology and efficacy in anaerobic bacterial infections.
    Pharmacotherapy (Pharmacotherapy ) Vol: 1 Issue 1 Pages: 28-38
    Pub: 1981 Jul-Aug Epub:
    • Tally FP
    • Sullivan CE

  10. Antibiotic use in childhood alters the gut microbiota and predisposes to overweight
    Microbial Cell (Microb Cell ) Vol: 3 Issue 7 Pages: 296-298
    Pub: 2016 Jun 20 Epub: 2016 Jun 20
    • Korpela K
    • de Vos WM

Full list available by paid subscriptions

For More information see this summary.